Comparison between Accretion Nutraveda IPO and SJP Ultrasonic IPO.
Accretion Nutraveda IPO is a SME Fixed Price IPO proposed to list at BSE SME while SJP Ultrasonic IPO is a SME Fixed Price proposed to list at BSE SME.
| Accretion Nutraveda IPO | SJP Ultrasonic IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Sobhagya Capital Options Pvt.Ltd. | Khandwala Securities Ltd. |
| Registrar | Kfin Technologies Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Sunflower Broking Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Accretion Nutraveda IPO is up to ₹23.53 Cr whereas the issue size of the SJP Ultrasonic IPO is up to ₹0.00 Cr. The final issue price of Accretion Nutraveda IPO is ₹129.00 per share and of SJP Ultrasonic IPO is .
| Accretion Nutraveda IPO | SJP Ultrasonic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹122.00 per share | |
| Issue Price (Upper) | ₹129.00 per share | |
| Issue Price (Final) | ₹129.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | |
| Fresh Issue Size | 18,24,000 shares | 35,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹23.53 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 18,24,000 shares | 35,00,000 shares |
| Issue Size Total (Amount) | up to ₹23.53 Cr | up to ₹0.00 Cr |
Accretion Nutraveda IPO opens on Jan 28, 2026, while SJP Ultrasonic IPO opens on . The closing date of Accretion Nutraveda IPO and SJP Ultrasonic IPO is Jan 30, 2026, and , respectively.
| Accretion Nutraveda IPO | SJP Ultrasonic IPO | |
|---|---|---|
| Anchor Bid Date | Jan 27, 2026 | |
| Issue Open | Jan 28, 2026 | |
| Issue Close | Jan 30, 2026 | |
| Basis Of Allotment (Tentative) | Feb 02, 2026 | |
| Initiation of Refunds (Tentative) | Feb 03, 2026 | |
| Credit of Share (Tentative) | Feb 03, 2026 | |
| Listing date (Tentative) | Feb 04, 2026 | |
| Anchor Lockin End date 1 | Mar 03, 2026 | |
| Anchor Lockin End date 2 | May 02, 2026 |
Accretion Nutraveda IPO P/E ratio is 26.27, as compared to SJP Ultrasonic IPO P/E ratio of .
| Accretion Nutraveda IPO | SJP Ultrasonic IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)SJP Ultrasonic Ltd.'s revenue increased by 39% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 95.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 26.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.40 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 81.22 | 38.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 36.98 | 50.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.72 | 0.16 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.91 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 48.85 | 28.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Accretion Nutraveda IPO Retail Individual Investors (RII) are offered 6,40,000 shares while in SJP Ultrasonic IPO retail investors are offered 6,40,000 shares. Qualified Institutional Buyers (QIB) are offered 3,64,000 shares in Accretion Nutraveda IPO and 0 shares in SJP Ultrasonic IPO.
| Accretion Nutraveda IPO | SJP Ultrasonic IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,44,000 shares | 0 shares |
| Market Maker Reservation | 96,000 shares | 0 shares |
| QIB | 3,64,000 shares | 0 shares |
| NII | 2,76,000 shares | 0 shares |
| RII | 6,40,000 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 18,24,000 shares | 0 shares |
Accretion Nutraveda IPO subscribed 1.29x in total, whereas SJP Ultrasonic IPO subscribed .
| Accretion Nutraveda IPO | SJP Ultrasonic IPO | |
|---|---|---|
| QIB (times) | 1.01x | |
| NII (times) | 2.08x | |
| Big NII (times) | 1.95x | |
| Small NII (times) | 2.33x | |
| RII (times) | 2.19x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.29x |
